RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PASSIGLIA F
Collezione AO Ordine Mauriziano

Items : 11

Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 May;202:114006. doi: 10.1016/j.ejca.2024.114006. Epub 2024 Mar 11.

2024
AO Ordine Mauriziano

Leonetti A; Perrone F; Puntoni M; Maglietta G; Bordi P; Bria E; Vita E; Gelsomino F; De Giglio A; Gelibter A; Siringo M; Mazzoni F; Caliman E; Genova C; Bertolini F; Guaitoli G; Passiglia F; Delcuratolo MD; Montrone M; Cerea G; Pasello G; Roca E; Belluomini L; Cecere FL; Guida A; Manzo A; Adamo V; Rastelli F; Bulotta A; et alii...

Real-world retrospective study of KRAS mutations in advanced non-small cell lung cancer in the era of immunotherapy. in Cancer / Cancer. 2023 Jun 1;129(11):1662-1671. doi: 10.1002/cncr.34731. Epub 2023 Mar 11.

2023
AO Ordine Mauriziano

Bironzo P; Cani M; Jacobs F; Napoli VM; Listì A; Passiglia F; Righi L; Di Maio M; Novello S; Scagliotti GV;

Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center Experience. in Biomedicines / Biomedicines. 2023 Jan 9;11(1):165. doi: 10.3390/biomedicines11010165.

2023
AO Ordine Mauriziano

Persano I; Cani M; Del Rio B; Ferrari G; Garbo E; Parlagreco E; Pisano C; Cetoretta V; Delcuratolo MD; Turco F; Audisio A; Cecchi C; Leone G; Napoli VM; Bertaglia V; Bianco V; Capelletto E; D'Amiano C; Di Maio M; Gianetta M; Novello S; Passiglia F; Scagliotti GV; Bironzo P;

Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer. in Cells / Cells. 2022 Oct 14;11(20):3226. doi: 10.3390/cells11203226.

2022
AO Ordine Mauriziano

Mariniello A; Tabbò F; Indellicati D; Tesauro M; Rezmives NA; Reale ML; Listì A; Capelletto E; Carnio S; Bertaglia V; Mecca C; Consito L; De Filippis M; Bungaro M; Paratore C; Di Maio M; Passiglia F; Righi L; Sangiolo D; Novello S; Geuna M; Bironzo P;

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.

2022
AO Ordine Mauriziano

Cortellini A; Giusti R; Filetti M; Citarella F; Adamo V; Santini D; Buti S; Nigro O; Cantini L; Di Maio M; Aerts JGJV; Bria E; Bertolini F; Ferrara MG; Ghidini M; Grossi F; Guida A; Berardi R; Morabito A; Genova C; Mazzoni F; Antonuzzo L; Gelibter A; Marchetti P; Chiari R; Macerelli M; Rastelli F; Della Gravara L; Gori S; et alii...

Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations. in Cancers / Cancers (Basel). 2021 May 17;13(10):2425. doi: 10.3390/cancers13102425.

2021
AO Ordine Mauriziano

Scagliotti GV; Bussolino F; Righi L; Di Maio M; Passiglia F; Listì A; Caglio A; Tabbò F; Sperone T; Reale ML; Bironzo P; Novello S;

Descriptive Comparative Analysis of Patients With Cancer Referring to the Emergency Department of an Italian University Hospital Across the Severe Acute Respiratory Syndrome Coronavirus 2 Waves. in JCO oncology practice / JCO Oncol Pract. 2021 Dec;17(12):e1887-e1894. doi: 10.1200/OP.21.00098. Epub 2021 Jul 6.

2021
AO Ordine Mauriziano

Mariniello A; Bironzo P; Pisano C; De Filippis M; Persano I; Olmetto E; Caramello V; Boccuzzi A; Capelletto E; Passiglia F; Di Maio M; Novello S; Mariniello A; Bironzo P; Pisano C; De Filippis M; Persano I; Olmetto E; Caramello V; Boccuzzi A; Capelletto E; Passiglia F; Di Maio M; Novello S;

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy. in Journal for immunotherapy of cancer / J Immunother Cancer. 2021 Apr;9(4):e002421. doi: 10.1136/jitc-2021-002421.

2021
AO Ordine Mauriziano

Bironzo P; Metro G; Passiglia F; Migliorino MR; Ricciardi S; Landi L; Minuti G; Bordi P; Tuzi A; Cantini L; Russano M; Citarella F; Santini D; Filetti M; Zoratto F; Mansueto G; Di Marino P; Grassadonia A; Michele T; Inno A; Della Gravara L; Rocco D; Chiari R; Rastelli F; Macerelli M; Marchetti P; Siringo M; Gelibter A; Signorelli D; et alii...

First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 May;130:155-167. doi: 10.1016/j.ejca.2020.02.023. Epub 2020 Mar 25.

2020
AO Ordine Mauriziano

Facchinetti F; Mazzaschi G; Barbieri F; Passiglia F; Mazzoni F; Berardi R; Proto C; Cecere FL; Pilotto S; Scotti V; Rossi S; Del Conte A; Vita E; Bennati C; Ardizzoni A; Cerea G; Migliorino MR; Sala E; Camerini A; Bearz A; De Carlo E; Zanelli F; Guaitoli G; Garassino MC; Ciccone LP; Sartori G; Toschi L; Dall'Olio FG; Landi L; et alii...

The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis. in Scientific reports / Sci Rep. 2018 Sep 6;8(1):13379. doi: 10.1038/s41598-018-30780-4.

2018
AO Ordine Mauriziano

Passiglia F; Rizzo S; Di Maio M; Galvano A; Badalamenti G; Listì A; Gulotta L; Castiglia M; Fulfaro F; Bazan V; Russo A;

Publisher Correction: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis. in Scientific reports / Sci Rep. 2018 Nov 19;8(1):17270. doi: 10.1038/s41598-018-35524-y.

2018
AO Ordine Mauriziano

Passiglia F; Rizzo S; Di Maio M; Galvano A; Badalamenti G; Listì A; Gulotta L; Castiglia M; Fulfaro F; Bazan V; Russo A;